Corrigendum: Pharmacological activity and clinical use of PDRN.

DNA PDRN adenosine A2 receptors oligonucleotides wound healing

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 18 10 2022
accepted: 19 10 2022
entrez: 8 12 2022
pubmed: 9 12 2022
medline: 9 12 2022
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fphar.2017.00224.].

Identifiants

DOI: 10.3389/fphar.2022.1073510 PMID: 36479198 PMC: PMC9721529
pubmed: 36479198
doi: 10.3389/fphar.2022.1073510
pii: 1073510
pmc: PMC9721529
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1073510

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2022 Squadrito, Bitto, Irrera, Pizzino, Pallio, Minutoli and Altavilla.

Auteurs

Francesco Squadrito (F)

Section of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Alessandra Bitto (A)

Section of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Natasha Irrera (N)

Section of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Gabriele Pizzino (G)

Section of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Giovanni Pallio (G)

Section of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Letteria Minutoli (L)

Section of Pharmacology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Domenica Altavilla (D)

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Classifications MeSH